Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of PREACT-AF is to learn if posterior pericardiotomy works to prevent the incidence of postoperative atrial fibrillation (POAF) in patients undergoing cardiac surgery.
The main questions it aims to answer are:
Does posterior pericardiotomy prevent the incidence of POAF for participants after cardiac surgery? What medical problems do participants have when undergoing posterior pericardiotomy?
Approximately 30% of cardiac surgical patients develop post-operative atrial fibrillation (POAF). Its incidence varies depending on the type of cardiac operation. POAF is associated with short- and long-term adverse events, including mortality, stroke, and heart failure. POAF has also been significantly associated with unplanned hospitalization for heart failure.
During cardiac surgery, pericardial fluid tends to collect posterior to the left atrium. Even small amounts of fluid may trigger atrial arrhythmias. A posterior left pericardiotomy is a surgical procedure that involves cauterizing an opening between the left inferior pulmonary vein and the diaphragm. This procedure may allow for more prolonged drainage of the pericardial fluid into the left pleural space. Recent research evidence found that posterior pericardiotomy was associated with a significantly lower incidence of POAF.
The existing data on posterior pericardiotomy is promising for a reduction in POAF. However, no high-quality study has demonstrated that this reduction improves clinical outcomes in the years after cardiac surgery. The PRINCE trial's long-term follow-up of patients randomized to left posterior pericardiotomy could conclusively demonstrate whether the relationship of POAF to post-discharge clinical outcomes is causal and modifiable.
The PRINCE trial will evaluate the effectiveness and safety of posterior left pericardiotomy in preventing POAF and improving post-discharge clinical outcomes in a broad spectrum of cardiac surgery patients.
The intervention under investigation is left posterior pericardiotomy which is compared to no posterior pericardiotomy during cardiac surgery. The early co-primary outcome is in-hospital POAF, and the late co-primary outcome is the hierarchical composite of time to all-cause death, time to ischemic stroke, time to systemic arterial embolism, time to unplanned hospital visit/readmission for cardiac reasons, and time to atrial fibrillation after index hospital discharge.
The study will enrol 1400 patients from 30 centres, globally. Follow-up visits will be performed in person or by telephone 1 and 6 months post-randomization (+7 days), and then every 6 months (+30 days) until an average follow-up of 5 years for the study participants (estimated to be 4 years after completion of enrolment).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Posterior Pericardiotomy Group | Experimental | The surgeon will perform posterior pericardiotomy during the patient's cardiac surgery. |
|
| No Posterior Pericardiotomy Group | No Intervention | The surgeon will not perform posterior pericardiotomy during the patient's cardiac surgery. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Posterior Pericardiotomy | Procedure | The surgeon will perform a posterior pericardiotomy while the patient is on cardiopulmonary bypass. In detail, the surgeon will use cautery to make a 4- to 5-cm opening in pericardium between the left inferior pulmonary vein and the diaphragm. Then a soft channel drain will be placed through the posterior pericardium, the pericardiotomy and into the left pleural space. |
| Measure | Description | Time Frame |
|---|---|---|
| In-hospital post-operative atrial fibrillation | Number of patients with post-operative atrial fibrillation within the first 5 days postoperatively or up to hospital discharge, whichever occurs first | Within 5 days after index cardiac surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Length of post-operative in-hospital stay | Length of time the patient in hospital after their index cardiac surgery | Over the duration of the follow-up period to a common end date (mean follow-up of 5 years). |
| Pericardial effusion without tamponade |
| Measure | Description | Time Frame |
|---|---|---|
| Number of patients with phrenic nerve injuries | Safety outcome | Within 30 days of index surgery |
| Number of patients with left pleural interventions | Safety outcome |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Hao Zhang, M.D. Ph.D. | Contact | 86-21-31161765 | 13818178916@163.com |
| Name | Affiliation | Role |
|---|---|---|
| Lin Han, M.D. Ph.D. | Naval Medical University Changhai Hospital | Principal Investigator |
| Hao Zhang, M.D. Ph.D. | Naval Medical University Changhai Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Changhai Hospital | Shanghai | 200433 | China |
Not provided
| ID | Term |
|---|---|
| D001281 | Atrial Fibrillation |
| D002318 | Cardiovascular Diseases |
| ID | Term |
|---|---|
| D001145 | Arrhythmias, Cardiac |
| D006331 | Heart Diseases |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
Number of pericardial effusions that occur, excluding cardiac tamponade
| From index surgery completion to within 30 days of index surgery |
| Death | Occurrence of death | From index surgery completion to within 30 days of index surgery |
| Ischemic stroke or systemic arterial embolism | Number of ischemic strokes or systemic arterial embolisms | From index surgery completion to within 30 days of index surgery |
| Hospital readmission or unplanned hospital visit | Number of hospital readmissions or unplanned hospital visits | From index surgery completion to within 30 days of index surgery |
| Quality of life assessed by the European quality of life index version 5D (EQ-5D-5L) questionnaire | The EQ-5D-5L consists of a descriptive system and the EQ visual analogue scale (EQ VAS) scale of 0-100 where the endpoints are labelled 'The best health you can image' and 'The worst health you can imagine'. The VAS can be used as a quantitative measure of health outcome that reflects the patient's own judgement. The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension is measured on a 5 point scale: no problems, slight problems, moderate problems, severe problems and extreme problems. | Over the duration of the follow-up (mean follow-up of 5 years) |
| Within 30 days of index surgery |
| Number of patients with esophageal injuries | Safety outcome | Within 30 days of index surgery |
| Number of patients requiring re-operation for bleeding | Safety outcome | Within 48 hours of index surgery completion |
| Number of patients with cardiac tamponade | Safety outcome | Within 30 days of index surgery |